Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
1983-5-5
pubmed:abstractText
Complement-dependent lymphocytotoxic autoantibodies (CLA) are invariably present in sera of patients with active systemic lupus erythematosus (SLE). This study aimed to test for the influence of such antibodies on the in vitro generation of human alloantigen reactive proliferative and cytotoxic T cell responses. Unsensitized or alloantigen primed memory cells were pre-treated with CLA in the presence or absence of complement. Following stimulation of the remaining cells with allogeneic peripheral blood mononuclears, the proliferative and cytotoxic capacity was evaluated. Results indicated that only pre-treatment with CLA and complement influenced these reactions whereas in the absence of complement antibodies were totally ineffective. Pre-treatment of unsensitized precursor cells reduced and delayed both proliferative and cytotoxic reactivity; in contrast, pre-treatment of memory cells exclusively reduced cellular cytotoxicity. It thus appears that such SLE associated autoantibodies in the presence of complement are capable of modifying the balance between different subsets of alloreactive T cells.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/6219834-1082732, http://linkedlifedata.com/resource/pubmed/commentcorrection/6219834-1085685, http://linkedlifedata.com/resource/pubmed/commentcorrection/6219834-1133171, http://linkedlifedata.com/resource/pubmed/commentcorrection/6219834-14194983, http://linkedlifedata.com/resource/pubmed/commentcorrection/6219834-142641, http://linkedlifedata.com/resource/pubmed/commentcorrection/6219834-153749, http://linkedlifedata.com/resource/pubmed/commentcorrection/6219834-19534, http://linkedlifedata.com/resource/pubmed/commentcorrection/6219834-312810, http://linkedlifedata.com/resource/pubmed/commentcorrection/6219834-382506, http://linkedlifedata.com/resource/pubmed/commentcorrection/6219834-4149592, http://linkedlifedata.com/resource/pubmed/commentcorrection/6219834-463182, http://linkedlifedata.com/resource/pubmed/commentcorrection/6219834-6454727, http://linkedlifedata.com/resource/pubmed/commentcorrection/6219834-6965950, http://linkedlifedata.com/resource/pubmed/commentcorrection/6219834-698397, http://linkedlifedata.com/resource/pubmed/commentcorrection/6219834-6991173, http://linkedlifedata.com/resource/pubmed/commentcorrection/6219834-84029
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0009-9104
pubmed:author
pubmed:issnType
Print
pubmed:volume
50
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
525-33
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1982
pubmed:articleTitle
Complement-dependent lymphocytotoxic antibodies (CLA) in systemic lupus erythematosus preferentially inhibit the generation of alloreactive cytotoxic T cells in secondary CML.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't